For Oncology Nurses: Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards

From Oncology Today with Dr Neil Love Dr. Neil Love

Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.

NCPD information and select publications here.

Community discussion

Join the conversation

For Oncology Nurses: Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards

You May Also Like

KI verstehen

La Science, CQFD

IQ - Wissenschaft und Forschung

Engines of Our Ingenuity

The Grave Talks | Haunted, Paranormal & Supernatural

Real Ghost Stories Online

Vedanta Cast

Hiçbir Şey Tesadüf Değil

Into The Parabnormal

Deep Marine Scenes